{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T04:02:18Z","timestamp":1794283338774,"version":"4.9.0"},"reference-count":82,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,11,17]],"date-time":"2020-11-17T00:00:00Z","timestamp":1605571200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,11,17]],"date-time":"2020-11-17T00:00:00Z","timestamp":1605571200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100010661","name":"EC | Horizon 2020 Framework Programme","doi-asserted-by":"publisher","award":["101003627"],"award-info":[{"award-number":["101003627"]}],"id":[{"id":"10.13039\/100010661","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010661","name":"EC | Horizon 2020 Framework Programme","doi-asserted-by":"publisher","award":["733176"],"award-info":[{"award-number":["733176"]}],"id":[{"id":"10.13039\/100010661","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","award":["INV-00636"],"award-info":[{"award-number":["INV-00636"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003130","name":"Fonds Wetenschappelijk Onderzoek","doi-asserted-by":"publisher","award":["VirEOS 30981113"],"award-info":[{"award-number":["VirEOS 30981113"]}],"id":[{"id":"10.13039\/501100003130","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012220","name":"Hercules Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012220","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Emergence of SARS-CoV-2 causing COVID-19 has resulted in hundreds of thousands of deaths. In search for key targets of effective therapeutics, robust animal models mimicking COVID-19 in humans are urgently needed. Here, we show that Syrian hamsters, in contrast to mice, are highly permissive to SARS-CoV-2 and develop bronchopneumonia and strong inflammatory responses in the lungs with neutrophil infiltration and edema, further confirmed as consolidations visualized by micro-CT alike in clinical practice. Moreover, we identify an exuberant innate immune response as key player in pathogenesis, in which STAT2 signaling plays a dual role, driving severe lung injury on the one hand, yet restricting systemic virus dissemination on the other. Our results reveal the importance of STAT2-dependent interferon responses in the pathogenesis and virus control during SARS-CoV-2 infection and may help rationalizing new strategies for the treatment of COVID-19 patients.<\/jats:p>","DOI":"10.1038\/s41467-020-19684-y","type":"journal-article","created":{"date-parts":[[2020,11,17]],"date-time":"2020-11-17T11:03:31Z","timestamp":1605611011000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":262,"title":["STAT2 signaling restricts viral dissemination but drives severe pneumonia in SARS-CoV-2 infected hamsters"],"prefix":"10.1038","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5984-7279","authenticated-orcid":false,"given":"Robbert","family":"Boudewijns","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5785-8276","authenticated-orcid":false,"given":"Hendrik Jan","family":"Thibaut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7935-0219","authenticated-orcid":false,"given":"Suzanne J. F.","family":"Kaptein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4436-3212","authenticated-orcid":false,"given":"Valentijn","family":"Vergote","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Seldeslachts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johan","family":"Van Weyenbergh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolien","family":"De Keyzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lindsey","family":"Bervoets","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3493-252X","authenticated-orcid":false,"given":"Sapna","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5616-8548","authenticated-orcid":false,"given":"Laurens","family":"Liesenborghs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9344-131X","authenticated-orcid":false,"given":"Sander","family":"Jansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominique","family":"Van Looveren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Vercruysse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9265-6028","authenticated-orcid":false,"given":"Dirk","family":"Jochmans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik","family":"Martens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5270-4603","authenticated-orcid":false,"given":"Kenny","family":"Roose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorien","family":"De Vlieger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bert","family":"Schepens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tina","family":"Van Buyten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8657-6841","authenticated-orcid":false,"given":"Sofie","family":"Jacobs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0005-9761","authenticated-orcid":false,"given":"Joan","family":"Mart\u00ed-Carreras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8350-4356","authenticated-orcid":false,"given":"Bert","family":"Vanmechelen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tony","family":"Wawina-Bokalanga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8874-675X","authenticated-orcid":false,"given":"Leen","family":"Delang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joana","family":"Rocha-Pereira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lotte","family":"Coelmont","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5236-623X","authenticated-orcid":false,"given":"Winston","family":"Chiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pieter","family":"Leyssen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4359-7225","authenticated-orcid":false,"given":"Elisabeth","family":"Heylen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominique","family":"Schols","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lanjiao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lila","family":"Close","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1188-9733","authenticated-orcid":false,"given":"Jelle","family":"Matthijnssens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Van Ranst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veerle","family":"Compernolle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2251-3195","authenticated-orcid":false,"given":"Georg","family":"Schramm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5200-7245","authenticated-orcid":false,"given":"Koen","family":"Van Laere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3861-6965","authenticated-orcid":false,"given":"Xavier","family":"Saelens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2069-6917","authenticated-orcid":false,"given":"Nico","family":"Callewaert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1714-2294","authenticated-orcid":false,"given":"Ghislain","family":"Opdenakker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4571-5232","authenticated-orcid":false,"given":"Piet","family":"Maes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4246-6303","authenticated-orcid":false,"given":"Birgit","family":"Weynand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5975-0354","authenticated-orcid":false,"given":"Christopher","family":"Cawthorne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5633-3993","authenticated-orcid":false,"given":"Greetje","family":"Vande Velde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2441-4729","authenticated-orcid":false,"given":"Zhongde","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0033-7514","authenticated-orcid":false,"given":"Johan","family":"Neyts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8117-9166","authenticated-orcid":false,"given":"Kai","family":"Dallmeier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,11,17]]},"reference":[{"key":"19684_CR1","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1038\/s41579-018-0118-9","volume":"17","author":"J Cui","year":"2019","unstructured":"Cui, J., Li, F. & Shi, Z. L. Origin and evolution of pathogenic coronaviruses. Nat. Rev. Microbiol. 17, 181\u2013192 (2019).","journal-title":"Nat. Rev. Microbiol."},{"key":"19684_CR2","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1056\/NEJMoa2001017","volume":"382","author":"N Zhu","year":"2020","unstructured":"Zhu, N. et al. A novel coronavirus from patients with pneumonia in China, 2019. N. Engl. J. Med. 382, 727\u2013733 (2020).","journal-title":"N. Engl. J. Med."},{"key":"19684_CR3","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1016\/j.jinf.2020.03.004","volume":"80","author":"J Chen","year":"2020","unstructured":"Chen, J. et al. Clinical progression of patients with COVID-19 in Shanghai, China. J. Infect. 80, e1 (2020).","journal-title":"J. Infect."},{"key":"19684_CR4","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.chom.2016.01.007","volume":"19","author":"R Channappanavar","year":"2016","unstructured":"Channappanavar, R. et al. Dysregulated type I interferon and inflammatory monocyte-macrophage responses cause lethal pneumonia in SARS-CoV-infected mice. Cell Host Microbe 19, 181\u2013193 (2016).","journal-title":"Cell Host Microbe"},{"key":"19684_CR5","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1007\/s00281-017-0629-x","volume":"39","author":"R Channappanavar","year":"2017","unstructured":"Channappanavar, R. & Perlman, S. Pathogenic human coronavirus infections: causes and consequences of cytokine storm and immunopathology. Semin. Immunopathol. 39, 529\u2013539 (2017).","journal-title":"Semin. Immunopathol."},{"key":"19684_CR6","doi-asserted-by":"publisher","first-page":"13334","DOI":"10.1128\/JVI.01689-12","volume":"86","author":"C Page","year":"2012","unstructured":"Page, C. et al. Induction of alternatively activated macrophages enhances pathogenesis during severe acute respiratory syndrome coronavirus infection. J. Virol. 86, 13334\u201313349 (2012).","journal-title":"J. Virol."},{"key":"19684_CR7","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1001\/jama.2020.1585","volume":"323","author":"D Wang","year":"2020","unstructured":"Wang, D. et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA 323, 1061\u20131069 (2020).","journal-title":"JAMA"},{"key":"19684_CR8","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","volume":"395","author":"C Huang","year":"2020","unstructured":"Huang, C. et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 395, 497\u2013506 (2020).","journal-title":"Lancet"},{"key":"19684_CR9","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1126\/science.abb7314","volume":"368","author":"B Rockx","year":"2020","unstructured":"Rockx, B. et al. Comparative pathogenesis of COVID-19, MERS, and SARS in a nonhuman primate model. Science 368, 1012\u20131015 (2020).","journal-title":"Science"},{"key":"19684_CR10","doi-asserted-by":"publisher","first-page":"271.e8","DOI":"10.1016\/j.cell.2020.02.052","volume":"181","author":"M Hoffmann","year":"2020","unstructured":"Hoffmann, M. et al. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell 181, 271.e8\u2013280.e8 (2020).","journal-title":"Cell"},{"key":"19684_CR11","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1111\/j.1348-0421.2008.00097.x","volume":"53","author":"K Ishii","year":"2009","unstructured":"Ishii, K. et al. Neutralizing antibody against severe acute respiratory syndrome (SARS)-coronavirus spike is highly effective for the protection of mice in the murine SARS model. Microbiol. Immunol. 53, 75\u201382 (2009).","journal-title":"Microbiol. Immunol."},{"key":"19684_CR12","doi-asserted-by":"publisher","first-page":"2601","DOI":"10.1099\/vir.0.046284-0","volume":"93","author":"T Mahlak\u00f5iv","year":"2012","unstructured":"Mahlak\u00f5iv, T. et al. Combined action of type I and type III interferon restricts initial replication of severe acute respiratory syndrome coronavirus in the lung but fails to inhibit systemic virus spread. J. Gen. Virol. 93, 2601\u20132605 (2012).","journal-title":"J. Gen. Virol."},{"key":"19684_CR13","doi-asserted-by":"crossref","unstructured":"Sharma, S. et al. Small molecule inhibitors of TBK1 serve as adjuvant for a plasmid-launched live-attenuated yellow fever vaccine. Hum. Vaccines Immunother. 16, 2196\u20132203 (2020).","DOI":"10.1080\/21645515.2020.1765621"},{"key":"19684_CR14","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1146\/annurev-virology-092818-015756","volume":"6","author":"JW Schoggins","year":"2019","unstructured":"Schoggins, J. W. Interferon-stimulated genes: what do they all do? Annu. Rev. Virol. 6, 567\u2013584 (2019).","journal-title":"Annu. Rev. Virol."},{"key":"19684_CR15","doi-asserted-by":"crossref","unstructured":"Khouri, R. et al. A genetic IFN\/STAT1\/FAS axis determines CD4 T stem cell memory levels and apoptosis in healthy controls and Adult T-cell Leukemia patients. Oncoimmunology 7, e1426423 (2018).","DOI":"10.1080\/2162402X.2018.1426423"},{"key":"19684_CR16","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1189\/jlb.70.5.745","volume":"70","author":"J Van Weyenbergh","year":"2001","unstructured":"Van Weyenbergh, J., Wietzerbin, J., Rouillard, D., Barral-Netto, M. & Liblau, R. Treatment of multiple sclerosis patients with interferon-beta primes monocyte-derived macrophages for apoptotic cell death. J. Leukoc. Biol. 70, 745\u2013748 (2001).","journal-title":"J. Leukoc. Biol."},{"key":"19684_CR17","doi-asserted-by":"crossref","unstructured":"Delgobo, M. et al. An evolutionary recent IFN\/IL-6\/CEBP axis is linked to monocyte expansion and tuberculosis severity in humans. Elife 8, e47013 (2019).","DOI":"10.7554\/eLife.47013"},{"key":"19684_CR18","doi-asserted-by":"publisher","first-page":"e35","DOI":"10.1016\/S0140-6736(20)30305-6","volume":"395","author":"A Zumla","year":"2020","unstructured":"Zumla, A., Hui, D. S., Azhar, E. I., Memish, Z. A. & Maeurer, M. Reducing mortality from 2019-nCoV: host-directed therapies should be an option. Lancet 395, e35\u2013e36 (2020).","journal-title":"Lancet"},{"key":"19684_CR19","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1128\/JVI.79.1.503-511.2005","volume":"79","author":"A Roberts","year":"2005","unstructured":"Roberts, A. et al. Severe acute respiratory syndrome coronavirus infection of golden Syrian hamsters. J. Virol. 79, 503\u2013511 (2005).","journal-title":"J. Virol."},{"key":"19684_CR20","doi-asserted-by":"publisher","unstructured":"Chan, J. F.-W. et al. Simulation of the clinical and pathological manifestations of Coronavirus Disease 2019 (COVID-19) in golden Syrian hamster model: implications for disease pathogenesis and transmissibility. Clin. Infect. Dis. https:\/\/doi.org\/10.1093\/cid\/ciaa325 (2020).","DOI":"10.1093\/cid\/ciaa325"},{"key":"19684_CR21","doi-asserted-by":"crossref","unstructured":"Sia, S. F. et al. Pathogenesis and transmission of SARS-CoV-2 in golden hamsters. Nature 583, 834\u2013838 (2020).","DOI":"10.1038\/s41586-020-2342-5"},{"key":"19684_CR22","doi-asserted-by":"crossref","first-page":"16587","DOI":"10.1073\/pnas.2009799117","volume":"117","author":"M Imai","year":"2020","unstructured":"Imai, M. et al. Syrian hamsters as a small animal model for SARS-CoV-2 infection and countermeasure development. Proc. Natl Acad. Sci. USA 117, 16587\u201316595 (2020).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"19684_CR23","doi-asserted-by":"crossref","unstructured":"Wrapp, D. et al. Structural basis for potent neutralization of betacoronaviruses by single-domain camelid antibodies. Cell 181, 1436\u20131441 (2020).","DOI":"10.1016\/j.cell.2020.05.047"},{"key":"19684_CR24","doi-asserted-by":"crossref","unstructured":"Fan, Z. et al. Efficient gene targeting in golden Syrian hamsters by the CRISPR\/Cas9 system. PLoS ONE 9, e109755 (2014).","DOI":"10.1371\/journal.pone.0109755"},{"key":"19684_CR25","doi-asserted-by":"publisher","first-page":"e1005084","DOI":"10.1371\/journal.ppat.1005084","volume":"11","author":"K Toth","year":"2015","unstructured":"Toth, K. et al. STAT2 knockout Syrian hamsters support enhanced replication and pathogenicity of human adenovirus, revealing an important role of type I interferon response in viral control. PLoS Pathog. 11, e1005084 (2015).","journal-title":"PLoS Pathog."},{"key":"19684_CR26","doi-asserted-by":"crossref","unstructured":"Lin, L. et al. Gastrointestinal symptoms of 95 cases with SARS-CoV-2 infection. Gut 69, 997\u20131001 (2020).","DOI":"10.1136\/gutjnl-2020-321013"},{"key":"19684_CR27","doi-asserted-by":"crossref","unstructured":"Bagca, B. G. & Avci, C. B. The potential of JAK\/STAT pathway inhibition by ruxolitinib in the treatment of COVID-19. Cytokine Growth Factor Rev. 54, 51\u201361 (2020).","DOI":"10.1016\/j.cytogfr.2020.06.013"},{"key":"19684_CR28","doi-asserted-by":"crossref","unstructured":"Felgenhauer, U. et al. Inhibition of SARS-CoV-2 by type I and type III interferons. J. Biol. Chem. 295, 13958\u201313964 (2020).","DOI":"10.1074\/jbc.AC120.013788"},{"key":"19684_CR29","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1016\/S2213-2600(20)30076-X","volume":"8","author":"Z Xu","year":"2020","unstructured":"Xu, Z. et al. Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir. Med. 8, 420\u2013422 (2020).","journal-title":"Lancet Respir. Med."},{"key":"19684_CR30","doi-asserted-by":"crossref","unstructured":"Ai, T. et al. Correlation of chest CT and RT-PCR testing in coronavirus disease 2019 (COVID-19) in China: a report of 1014 cases. Radiology 296, E32\u2013E40 (2020).","DOI":"10.1148\/radiol.2020200642"},{"key":"19684_CR31","doi-asserted-by":"publisher","first-page":"m1091","DOI":"10.1136\/bmj.m1091","volume":"368","author":"T Chen","year":"2020","unstructured":"Chen, T. et al. Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study. BMJ 368, m1091 (2020).","journal-title":"BMJ"},{"key":"19684_CR32","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/S1473-3099(20)30086-4","volume":"20","author":"H Shi","year":"2020","unstructured":"Shi, H. et al. Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study. Lancet Infect. Dis. 20, 425\u2013434 (2020).","journal-title":"Lancet Infect. Dis."},{"key":"19684_CR33","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1038\/labinvest.2016.45","volume":"96","author":"J Poelmans","year":"2016","unstructured":"Poelmans, J. et al. Longitudinal, in vivo assessment of invasive pulmonary aspergillosis in mice by computed tomography and magnetic resonance imaging. Lab. Investig. 96, 692\u2013704 (2016).","journal-title":"Lab. Investig."},{"key":"19684_CR34","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1242\/dmm.020321","volume":"9","author":"GVande Velde","year":"2016","unstructured":"Vande Velde, G. et al. Longitudinal micro-CT provides biomarkers of lung disease that can be used to assess the effect of therapy in preclinical mouse models, and reveal compensatory changes in lung volume. DMM Dis. Model. Mech. 9, 91\u201398 (2016).","journal-title":"DMM Dis. Model. Mech."},{"key":"19684_CR35","doi-asserted-by":"crossref","unstructured":"de Langhe, E. et al. Quantification of lung fibrosis and emphysema in mice using automated micro-computed tomography. PLoS ONE 7, e43123 (2012).","DOI":"10.1371\/journal.pone.0043123"},{"key":"19684_CR36","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.jim.2011.02.004","volume":"368","author":"M Zivcec","year":"2011","unstructured":"Zivcec, M., Safronetz, D., Haddock, E., Feldmann, H. & Ebihara, H. Validation of assays to monitor immune responses in the Syrian golden hamster (Mesocricetus auratus). J. Immunol. Methods 368, 24\u201335 (2011).","journal-title":"J. Immunol. Methods"},{"key":"19684_CR37","doi-asserted-by":"publisher","first-page":"1016.e19","DOI":"10.1016\/j.cell.2020.04.035","volume":"181","author":"CGK Ziegler","year":"2020","unstructured":"Ziegler, C. G. K. et al. SARS-CoV-2 receptor ACE2 is an interferon-stimulated gene in human airway epithelial cells and is detected in specific cell subsets across tissues. Cell 181, 1016.e19\u20131035.e19 (2020).","journal-title":"Cell"},{"key":"19684_CR38","doi-asserted-by":"publisher","unstructured":"Onabajo, O. O. et al. Interferons and viruses induce a novel primate-specific isoform dACE2 and not the SARS-CoV-2 receptor ACE2. Preprint at https:\/\/doi.org\/10.1101\/2020.07.19.210955 (2020).","DOI":"10.1101\/2020.07.19.210955"},{"key":"19684_CR39","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1128\/JVI.02012-06","volume":"81","author":"PB Mccray","year":"2007","unstructured":"Mccray, P. B. et al. Lethal infection of K18-hACE2 mice infected with severe acute respiratory syndrome coronavirus. J. Virol. 81, 813\u2013821 (2007).","journal-title":"J. Virol."},{"key":"19684_CR40","doi-asserted-by":"crossref","unstructured":"Jiang, R. Di et al. Pathogenesis of SARS-CoV-2 in transgenic mice expressing human angiotensin-converting enzyme 2. Cell 182, 50.e8\u201358.e8 (2020).","DOI":"10.1016\/j.cell.2020.05.027"},{"key":"19684_CR41","doi-asserted-by":"crossref","unstructured":"Bao, L. et al. The pathogenicity of SARS-CoV-2 in hACE2 transgenic mice. Nature 583, 830\u2013833 (2020).","DOI":"10.1038\/s41586-020-2312-y"},{"key":"19684_CR42","doi-asserted-by":"crossref","unstructured":"Sun, S. H. et al. A mouse model of SARS-CoV-2 infection and pathogenesis. Cell Host Microbe 28, 124.e34\u2013133.e4 (2020).","DOI":"10.1016\/j.chom.2020.05.020"},{"key":"19684_CR43","first-page":"450","volume":"57","author":"XH Yang","year":"2007","unstructured":"Yang, X. H. et al. Mice transgenic for human angiotensin-converting enzyme 2 provide a model for SARS coronavirus infection. Comp. Med. 57, 450\u2013459 (2007).","journal-title":"Comp. Med."},{"key":"19684_CR44","doi-asserted-by":"crossref","unstructured":"Gu, H. et al. Adaptation of SARS-CoV-2 in BALB\/c mice for testing vaccine efficacy. Science 369, 1603\u20131607 (2020).","DOI":"10.1126\/science.abc4730"},{"key":"19684_CR45","doi-asserted-by":"publisher","first-page":"5670","DOI":"10.1128\/JVI.00272-10","volume":"84","author":"M Mordstein","year":"2010","unstructured":"Mordstein, M. et al. Lambda interferon renders epithelial cells of the respiratory and gastrointestinal tracts resistant to viral infections. J. Virol. 84, 5670\u20135677 (2010).","journal-title":"J. Virol."},{"key":"19684_CR46","doi-asserted-by":"crossref","unstructured":"Hassan, A. O. et al. A SARS-CoV-2 infection model in mice demonstrates protection by neutralizing antibodies. Cell 182, 744.e4\u2013753.e4 (2020).","DOI":"10.1016\/j.cell.2020.06.011"},{"key":"19684_CR47","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1038\/s41577-020-0311-8","volume":"20","author":"MZ Tay","year":"2020","unstructured":"Tay, M. Z., Poh, C. M., R\u00e9nia, L., MacAry, P. A. & Ng, L. F. P. The trinity of COVID-19: immunity, inflammation and intervention. Nat. Rev. Immunol. 20, 363\u2013374 (2020).","journal-title":"Nat. Rev. Immunol."},{"key":"19684_CR48","doi-asserted-by":"publisher","first-page":"102763","DOI":"10.1016\/j.ebiom.2020.102763","volume":"55","author":"J Liu","year":"2020","unstructured":"Liu, J. et al. Longitudinal characteristics of lymphocyte responses and cytokine profiles in the peripheral blood of SARS-CoV-2 infected patients. EBioMedicine 55, 102763 (2020).","journal-title":"EBioMedicine"},{"key":"19684_CR49","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1038\/s41591-020-0820-9","volume":"26","author":"KG Andersen","year":"2020","unstructured":"Andersen, K. G., Rambaut, A., Lipkin, W. I., Holmes, E. C. & Garry, R. F. The proximal origin of SARS-CoV-2. Nat. Med. 26, 450\u2013452 (2020).","journal-title":"Nat. Med."},{"key":"19684_CR50","doi-asserted-by":"publisher","first-page":"1346.e2","DOI":"10.1016\/j.cub.2020.08.070","volume":"30","author":"T Zhang","year":"2020","unstructured":"Zhang, T., Wu, Q. & Zhang, Z. Probable pangolin origin of SARS-CoV-2 associated with the COVID-19 outbreak. Curr. Biol. 30, 1346.e2\u20131351.e2 (2020).","journal-title":"Curr. Biol."},{"key":"19684_CR51","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1126\/science.abb2507","volume":"367","author":"D Wrapp","year":"2020","unstructured":"Wrapp, D. et al. Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation. Science 367, 1260\u20131263 (2020).","journal-title":"Science"},{"key":"19684_CR52","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1080\/22221751.2020.1756700","volume":"9","author":"S-Y Lau","year":"2020","unstructured":"Lau, S.-Y. et al. Attenuated SARS-CoV-2 variants with deletions at the S1\/S2 junction. Emerg. Microbes Infect. 9, 837\u2013842 (2020).","journal-title":"Emerg. Microbes Infect."},{"key":"19684_CR53","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.ppat.1000849","volume":"6","author":"MB Frieman","year":"2010","unstructured":"Frieman, M. B. et al. SARS-CoV pathogenesis is regulated by a STAT1 dependent but a type I, II and III interferon receptor independent mechanism. PLoS Pathog. 6, 1\u201314 (2010).","journal-title":"PLoS Pathog."},{"key":"19684_CR54","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1016\/S1074-7613(00)00077-7","volume":"13","author":"C Park","year":"2000","unstructured":"Park, C., Li, S., Cha, E. & Schindler, C. Immune response in Stat2 knockout mice. Immunity 13, 795\u2013804 (2000).","journal-title":"Immunity"},{"key":"19684_CR55","doi-asserted-by":"crossref","unstructured":"Gowen, B. B. et al. Modeling severe fever with thrombocytopenia syndrome virus infection in golden Syrian hamsters: importance of STAT2 in preventing disease and effective treatment with favipiravir. J. Virol. 91, e01942-16 (2017).","DOI":"10.1128\/JVI.01942-16"},{"key":"19684_CR56","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.virol.2017.04.013","volume":"507","author":"V Siddharthan","year":"2017","unstructured":"Siddharthan, V. et al. Zika virus infection of adult and fetal STAT2 knock-out hamsters. Virology 507, 89\u201395 (2017).","journal-title":"Virology"},{"key":"19684_CR57","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.immuni.2012.01.011","volume":"36","author":"DJ Gough","year":"2012","unstructured":"Gough, D. J., Messina, N. L., Clarke, C. J. P., Johnstone, R. W. & Levy, D. E. Constitutive type I interferon modulates homeostatic balance through tonic signaling. Immunity 36, 166\u2013174 (2012).","journal-title":"Immunity"},{"key":"19684_CR58","doi-asserted-by":"crossref","unstructured":"Liu, L. et al. Anti-spike IgG causes severe acute lung injury by skewing macrophage responses during acute SARS-CoV infection. JCI Insight 4, e123158 (2019).","DOI":"10.1172\/jci.insight.123158"},{"key":"19684_CR59","doi-asserted-by":"crossref","unstructured":"Ochsner, S. A., Pillich, R. T. & McKenna, N. J. Consensus transcriptional regulatory networks of coronavirus-infected human cells. Sci. Data 7, 314 (2020).","DOI":"10.1038\/s41597-020-00628-6"},{"key":"19684_CR60","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1111\/jvh.13081","volume":"26","author":"C Yurdaydin","year":"2019","unstructured":"Yurdaydin, C. New treatment options for delta virus: is a cure in sight? J. Viral Hepat. 26, 618\u2013626 (2019).","journal-title":"J. Viral Hepat."},{"key":"19684_CR61","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.coi.2018.10.007","volume":"56","author":"E Andreakos","year":"2019","unstructured":"Andreakos, E., Zanoni, I. & Galani, I. E. Lambda interferons come to light: dual function cytokines mediating antiviral immunity and damage control. Curr. Opin. Immunol. 56, 67\u201375 (2019).","journal-title":"Curr. Opin. Immunol."},{"key":"19684_CR62","doi-asserted-by":"crossref","unstructured":"Prokunina-Olsson, L. et al. COVID-19 and emerging viral infections: the case for interferon lambda. J. Exp. Med. 217, e20200653 (2020).","DOI":"10.1084\/jem.20200653"},{"key":"19684_CR63","doi-asserted-by":"publisher","first-page":"eabc2061","DOI":"10.1126\/science.abc2061","volume":"369","author":"J Major","year":"2020","unstructured":"Major, J. et al. Type I and III interferons disrupt lung epithelial repair during recovery from viral infection. Science 369, eabc2061 (2020).","journal-title":"Science"},{"key":"19684_CR64","doi-asserted-by":"publisher","first-page":"eabc3545","DOI":"10.1126\/science.abc3545","volume":"369","author":"A Broggi","year":"2020","unstructured":"Broggi, A. et al. Type III interferons disrupt the lung epithelial barrier upon viral recognition. Science 369, eabc3545 (2020).","journal-title":"Science"},{"key":"19684_CR65","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1038\/cmi.2015.74","volume":"13","author":"Q Liu","year":"2016","unstructured":"Liu, Q., Zhou, Y. H. & Yang, Z. Q. The cytokine storm of severe influenza and development of immunomodulatory therapy. Cell. Mol. Immunol. 13, 3\u201310 (2016).","journal-title":"Cell. Mol. Immunol."},{"key":"19684_CR66","doi-asserted-by":"crossref","unstructured":"Cully, M. Immune status could determine efficacy of COVID-19 therapies. Nat. Rev. Drug Discov. 19, 431\u2013434 (2020).","DOI":"10.1038\/d41573-020-00110-3"},{"key":"19684_CR67","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1016\/j.immuni.2019.03.026","volume":"50","author":"S Kang","year":"2019","unstructured":"Kang, S., Tanaka, T., Narazaki, M. & Kishimoto, T. Targeting interleukin-6 signaling in clinic. Immunity 50, 1007\u20131023 (2019).","journal-title":"Immunity"},{"key":"19684_CR68","doi-asserted-by":"publisher","unstructured":"Portsmore, S., Tran Nguyen, T. N., Beacham, E. & Neelakantan, P. Combined IL-6 and JAK\/STAT inhibition therapy in COVID-19-related sHLH, potential game changer. Br. J. Haematol. https:\/\/doi.org\/10.1111\/bjh.16966 (2020).","DOI":"10.1111\/bjh.16966"},{"key":"19684_CR69","doi-asserted-by":"publisher","unstructured":"Jordan, S. C. et al. Compassionate use of tocilizumab for treatment of SARS-CoV-2 pneumonia. Clin. Infect. Dis. https:\/\/doi.org\/10.1093\/cid\/ciaa812 (2020).","DOI":"10.1093\/cid\/ciaa812"},{"key":"19684_CR70","doi-asserted-by":"publisher","unstructured":"Morillas, J. A. et al. Tocilizumab therapy in five solid and composite tissue transplant recipients with early ARDS due to SARS-CoV-2. Am. J. Transplant. https:\/\/doi.org\/10.1111\/ajt.16080 (2020).","DOI":"10.1111\/ajt.16080"},{"key":"19684_CR71","doi-asserted-by":"crossref","unstructured":"Foss, F. M. et al. Attenuated novel SARS coronavirus 2 infection in an allogeneic hematopoietic stem cell transplant patient on ruxolitinib. Clin. Lymphoma Myeloma Leuk. 20, 720\u2013723 (2020).","DOI":"10.1016\/j.clml.2020.06.014"},{"key":"19684_CR72","doi-asserted-by":"crossref","unstructured":"Koschmieder, S. et al. Favorable COVID-19 course despite significant comorbidities in a ruxolitinib-treated patient with primary myelofibrosis. Eur. J. Haematol. 105, 655\u2013658 (2020).","DOI":"10.1111\/ejh.13480"},{"key":"19684_CR73","doi-asserted-by":"crossref","unstructured":"Agostini, M. L. et al. Coronavirus susceptibility to the antiviral remdesivir (GS-5734) is mediated by the viral polymerase and the proofreading exoribonuclease. MBio 9, e00221-18 (2018).","DOI":"10.1128\/mBio.00221-18"},{"key":"19684_CR74","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1016\/j.cell.2013.06.022","volume":"154","author":"JK White","year":"2013","unstructured":"White, J. K. et al. XGenome-wide generation and systematic phenotyping of knockout mice reveals new roles for many genes. Cell 154, 452 (2013).","journal-title":"Cell"},{"key":"19684_CR75","unstructured":"Spiteri, G. et al. First cases of coronavirus disease 2019 (COVID-19) in the WHO European Region, 24 January to 21 February 2020. Euro Surveill. 25, 2000178 (2020)."},{"key":"19684_CR76","doi-asserted-by":"publisher","first-page":"e0008117","DOI":"10.1371\/journal.pntd.0008117","volume":"14","author":"B Vrancken","year":"2020","unstructured":"Vrancken, B. et al. Accounting for population structure reveals ambiguity in the Zaire Ebolavirus reservoir dynamics. PLoS Negl. Trop. Dis. 14, e0008117 (2020).","journal-title":"PLoS Negl. Trop. Dis."},{"key":"19684_CR77","doi-asserted-by":"publisher","first-page":"16532","DOI":"10.1038\/srep16532","volume":"5","author":"N Concei\u00e7\u00e3o-Neto","year":"2015","unstructured":"Concei\u00e7\u00e3o-Neto, N. et al. Modular approach to customise sample preparation procedures for viral metagenomics: a reproducible protocol for virome analysis. Sci. Rep. 5, 16532\u201316532 (2015).","journal-title":"Sci. Rep."},{"key":"19684_CR78","doi-asserted-by":"crossref","unstructured":"Concei\u00e7\u00e3o-Neto, N., Yinda, K. C., Van Ranst, M. & Matthijnssens, J. NetoVIR: modular approach to customize sample preparation procedures for viral metagenomics. Methods Mol. Biol. 1838, 85\u201395 (2018).","DOI":"10.1007\/978-1-4939-8682-8_7"},{"key":"19684_CR79","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ Livak","year":"2001","unstructured":"Livak, K. J. & Schmittgen, T. D. Analysis of relative gene expression data using real-time quantitative PCR and the 2\u2212\u0394\u0394CT method. Methods 25, 402\u2013408 (2001).","journal-title":"Methods"},{"key":"19684_CR80","doi-asserted-by":"crossref","unstructured":"Stewart, C. E., Rall, R. E. & Adamson, C. S. Inhibitors of the interferon response enhance virus replication in vitro. PLoS ONE 9, e112014 (2014).","DOI":"10.1371\/journal.pone.0112014"},{"key":"19684_CR81","doi-asserted-by":"publisher","first-page":"3305","DOI":"10.1109\/TNS.2013.2275994","volume":"60","author":"B Vandeghinste","year":"2013","unstructured":"Vandeghinste, B. et al. Iterative CT reconstruction using shearlet-based regularization. IEEE Trans. Nucl. Sci. 60, 3305\u20133317 (2013).","journal-title":"IEEE Trans. Nucl. Sci."},{"key":"19684_CR82","doi-asserted-by":"crossref","unstructured":"Berghen, N. et al. Radiosafe micro-computed tomography for longitudinal evaluation of murine disease models. Sci. Rep. 9, 17598 (2019).","DOI":"10.1038\/s41598-019-53876-x"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-020-19684-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-020-19684-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-020-19684-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T02:07:58Z","timestamp":1670292478000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-020-19684-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,17]]},"references-count":82,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["19684"],"URL":"https:\/\/doi.org\/10.1038\/s41467-020-19684-y","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,17]]},"assertion":[{"value":"18 September 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 October 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 November 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"D.D.V., B.S., and X.S. are named as inventors on US patent application no. 62\/988,610, entitled \u201cCoronavirus Binders.\u201d D.D.V., B.S., X.S., and N.C. are named as inventors on US patent application no. 62\/991,408, entitled \u201cSARS-CoV-2 Virus Binders.\u201d","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"5838"}}